Ron Dagan

32.1k total citations
597 papers, 22.2k citations indexed

About

Ron Dagan is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Ron Dagan has authored 597 papers receiving a total of 22.2k indexed citations (citations by other indexed papers that have themselves been cited), including 429 papers in Epidemiology, 203 papers in Microbiology and 90 papers in Infectious Diseases. Recurrent topics in Ron Dagan's work include Pneumonia and Respiratory Infections (359 papers), Respiratory viral infections research (212 papers) and Bacterial Infections and Vaccines (200 papers). Ron Dagan is often cited by papers focused on Pneumonia and Respiratory Infections (359 papers), Respiratory viral infections research (212 papers) and Bacterial Infections and Vaccines (200 papers). Ron Dagan collaborates with scholars based in Israel, United States and Germany. Ron Dagan's co-authors include Noga Givon‐Lavi, Eugene Leibovitz, Pablo Yagupsky, David Greenberg, Nurith Porat, Alberto Leiberman, Drora Fraser, Keith P. Klugman, David Greenberg and Michael R. Jacobs and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Ron Dagan

580 papers receiving 21.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ron Dagan Israel 77 15.6k 7.1k 3.5k 3.3k 3.2k 597 22.2k
Michael E. Pichichero United States 63 8.1k 0.5× 5.0k 0.7× 2.3k 0.7× 3.2k 1.0× 2.2k 0.7× 396 14.4k
Ellen R. Wald United States 65 7.7k 0.5× 2.1k 0.3× 2.6k 0.7× 2.2k 0.7× 3.1k 1.0× 302 14.9k
George H. McCracken United States 69 10.8k 0.7× 6.4k 0.9× 3.8k 1.1× 2.9k 0.9× 2.3k 0.7× 406 18.9k
Cynthia G. Whitney United States 68 21.2k 1.4× 6.8k 1.0× 2.5k 0.7× 3.7k 1.1× 2.1k 0.6× 256 26.0k
Nicola Principi Italy 63 8.8k 0.6× 2.0k 0.3× 1.4k 0.4× 3.9k 1.2× 2.6k 0.8× 591 16.5k
Sheldon L. Kaplan United States 69 11.1k 0.7× 5.2k 0.7× 7.5k 2.1× 11.3k 3.4× 2.1k 0.7× 361 26.0k
Keith P. Klugman United States 79 18.5k 1.2× 6.6k 0.9× 2.7k 0.8× 4.2k 1.3× 1.6k 0.5× 395 25.0k
Jerome O. Klein United States 52 4.8k 0.3× 2.7k 0.4× 2.0k 0.6× 1.1k 0.3× 2.7k 0.8× 260 10.6k
Merle A. Sande United States 61 7.3k 0.5× 2.2k 0.3× 2.1k 0.6× 4.6k 1.4× 1.2k 0.4× 234 13.9k
Scott F. Dowell United States 56 11.0k 0.7× 1.6k 0.2× 1.8k 0.5× 4.6k 1.4× 2.8k 0.9× 139 18.0k

Countries citing papers authored by Ron Dagan

Since Specialization
Citations

This map shows the geographic impact of Ron Dagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Dagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Dagan more than expected).

Fields of papers citing papers by Ron Dagan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Dagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Dagan. The network helps show where Ron Dagan may publish in the future.

Co-authorship network of co-authors of Ron Dagan

This figure shows the co-authorship network connecting the top 25 collaborators of Ron Dagan. A scholar is included among the top collaborators of Ron Dagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron Dagan. Ron Dagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dagan, Ron & Bart Adriaan van der Beek. (2024). Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine Is Reduced in Infants Immunized During the Respiratory Viral Season. Clinical Infectious Diseases. 81(3). 679–686. 1 indexed citations
2.
Redfern, Andrew, Marieke M. van der Zalm, Pierre Goussard, et al.. (2023). Clinical Presentation and Outcome of Acute Respiratory Illnesses in South African Children During the COVID-19 Pandemic. The Pediatric Infectious Disease Journal. 42(8). 672–678. 3 indexed citations
3.
Rochman, D., Ron Dagan, Luca Fiorito, et al.. (2023). On the estimation of nuclide inventory and decay heat: a review from the EURAD European project. SHILAP Revista de lepidopterología. 9. 14–14. 10 indexed citations
5.
Quinn, Charles T., Richard T. Wiedmann, Daniel Jarovsky, et al.. (2022). Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study. Blood Advances. 7(3). 414–421. 6 indexed citations
7.
Wyllie, Anne L., Joshua L. Warren, Gili Regev‐Yochay, et al.. (2020). Serotype Patterns of Pneumococcal Disease in Adults Are Correlated With Carriage Patterns in Older Children. Clinical Infectious Diseases. 72(11). e768–e775. 11 indexed citations
8.
Lewnard, Joseph A., Noga Givon‐Lavi, Paula A. Tähtinen, & Ron Dagan. (2018). Pneumococcal Phenotype and Interaction with Nontypeable Haemophilus influenzae as Determinants of Otitis Media Progression. Infection and Immunity. 86(6). 16 indexed citations
9.
Guarino, Alfredo, Eugenia Bruzzese, Andrea Lo Vecchio, Ron Dagan, & Μαρία Τσολιά. (2013). Definitions and Outcomes of Nutritional Interventions in Children with Respiratory Infections: The Approach of the COMMENT Initiative. Annals of Nutrition and Metabolism. 63(3). 248–255. 7 indexed citations
11.
Vergison, Anne, Ron Dagan, Adriano Arguedas, et al.. (2010). Otitis media and its consequences: beyond the earache. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 64 indexed citations
12.
Colijn, Caroline, Ted Cohen, Christophe Fraser, et al.. (2009). What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae ?. Journal of The Royal Society Interface. 7(47). 905–919. 70 indexed citations
13.
Carbonell‐Estrany, Xavier, Eric A. F. Simões, Ron Dagan, et al.. (2009). Motavizumab for Prophylaxis of Respiratory Syncytial Virus in High-Risk Children: A Noninferiority Trial. PEDIATRICS. 125(1). e35–e51. 181 indexed citations
14.
Yagupsky, Pablo, Ronen Fluss, Laurence S. Freedman, et al.. (2009). Dissemination of Kingella kingae in the Community and Long-Term Persistence of Invasive Clones. The Pediatric Infectious Disease Journal. 28(8). 707–710. 51 indexed citations
15.
Mor, Zohar, et al.. (2009). Hepatitis A disease following the implementation of universal vaccination: Who is at risk?. Journal of Viral Hepatitis. 17(4). 293–297. 12 indexed citations
16.
Greenberg, David, et al.. (2008). Acute Otitis Media in Children. Pediatric Drugs. 10(2). 75–83. 41 indexed citations
17.
Dagan, Ron, et al.. (1998). A nationwide prospective surveillance study in Israel to document pediatric invasive infections, with an emphasis on Haemophilus influenzae type b infections. The Pediatric Infectious Disease Journal. 17(Supplement). S198–S203. 26 indexed citations
18.
Dagan, Ron, et al.. (1996). Reduction of pneumococcal nasopharyngeal carriage after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid in early infancy. 36. 150. 1 indexed citations
19.
Dagan, Ron. (1995). Fluoroquinolones in Paediatrics - 1995. Drugs. 49(Supplement 2). 92–99. 18 indexed citations
20.
Sniadack, David H., Benjamin Schwartz, Harvey B. Lipman, et al.. (1995). Potential interventions for the prevention of childhood pneumonia. The Pediatric Infectious Disease Journal. 14(6). 503–509. 189 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026